Participant | Gender | Age | Education | Diagnosis | Monthly income($) |
---|---|---|---|---|---|
I-P1 | Female | 46 | Junior middle school | Breast cancer | 414–691 |
I-P2 | Female | 25 | Undergraduate course | Breast cancer | 414–691 |
I-P3 | Male | 59 | Primary school | Esophagus cancer | 414–691 |
I-P4 | Female | 74 | Senior middle school | Lung cancer | 691–1105 |
I-P5 | Female | 54 | Junior middle school | Breast cancer | 691–1105 |
I-P6 | Male | 73 | Primary school | Lung cancer | <414 |
I-P7 | Male | 66 | Senior middle school | Skin cancer | >1381 |
I-P8 | Male | 22 | Undergraduate course | Nasopharyngeal cancer | 691–1105 |
I-P9 | Female | 42 | Senior middle school | Glioma | 691–1105 |
I-P10 | Female | 36 | Senior middle school | Cervical cancer | 691–1105 |
II-P1 | Male | 59 | Junior middle school | Cancer of mouth | 691–1105 |
II-P2 | Female | 29 | Senior middle school | Nasopharyngeal cancer | 691–1105 |
II-P3 | Female | 62 | Primary school | Cervical cancer | 691–1105 |
II-P4 | Male | 70 | Primary school | Rectal cancer | 691–1105 |
II-P5 | Female | 68 | Primary school | Ovarian cancer | 691–1105 |
II-P6 | Male | 64 | Primary school | Lung cancer | <414 |
II-P7 | Female | 46 | Junior middle school | Breast cancer | 691–1105 |